Sign in
8-K

Current Report

FATE THERAPEUTICS INC Filed Acc 0001193125-23-002504

Agreement ended · Exit or restructuring costs · Executive or director change · Other events

  • Item 1.02 Termination of a material definitive agreement
  • Item 2.05 Costs associated with exit or disposal activities
  • Item 5.02 Departure or appointment of directors or officers
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading d418503d8k.htm…